Nurix Therapeutics (NRIX) Q2 2026 Earnings

8AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.03
-0.86
-0.69
-0.52

Details

Expected EPS
-0.762556
Actual EPS
-0.79
Surprise EPS
-0.03
Surprise Percent
+3.6%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.79 per share for Q2 2026.

0 Comments

Share your thoughts